Skip to content
Rejuvenation Technologies Inc. logo

Rejuvenation Technologies Inc.

Rejuvenation Technologies Inc. is a YC Summer 2018 (S18) company. Based in Mountain View, CA, USA. Team of 2.

  • Anti-Aging
  • Gene Therapy
  • Nanomedicine

About Rejuvenation Technologies Inc.

GPAgent's own fund-neutral profile, written from public information. Updated Oct 5, 2026.

Summary

Rejuvenation Technologies Inc. develops mRNA-based therapies that lengthen telomeres, the protective DNA sequences that shorten as cells divide and age. Delivering TERT mRNA can reverse more than a decade of telomere shortening within days, targeting diseases driven by critically short telomeres, including pulmonary fibrosis, liver disease, and bone marrow failure. The company is translating this approach from the lab into clinical trials, replacing the absence of any approved treatment that addresses cellular aging at the chromosomal level.

From the Y Combinator listing

How Rejuvenation Technologies Inc. describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

We extend telomeres to extend the human health span

Delivery of TERT mRNA extends telomeres sufficiently in a few days to reverse over a decade of telomere shortening during normal aging. We are advancing TERT mRNA-based therapies to the clinic.

Facts

Industry
Healthcare / Healthcare -> Therapeutics
Location
Mountain View, CA, USA
Team size
2
Status
Active
Stage
Early

Founders (2)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works